Viola Zhu, MD, PhD of UC Irvine Health discusses the CTONG 1104 trial and the use of gefitinib for adjuvant treatment of patients with resected EGFR+ non-small cell lung cancer. This was recorded at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.
Abstract 8500: CTONG 1104: Adjuvant Treatment with Gefitinib in Resected EGFR+ NSCLC.
Advertisement